vimarsana.com

Page 9 - ஹைதராபாத் அடிப்படையிலானது டாக்டர் சிவப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

10,000 sachets of anti-Covid drug 2-DG to be available in market from Thursday, says Rajnath Singh | India News

The anti-Covid drug has been developed by the Defence Research and Development Organisation (DRDO). Launching the Services e-Health Assistance and Tele-consultation (SeHAT) OPD Portal via video conferencing, Singh lauded the armed forces, stating that it is a key step taken at a very critical time for the health of service personnel as it will reduce the load of the hospitals. Chief of Defence Staff Gen Bipin Rawat, Army Chief Gen M M Naravane, and Navy Chief Admiral Karambir Singh were among those who attended the event. Referring to the second wave of the Covid-19, the Defence Minister said, This wave of Covid is unprecedented and more dangerous than earlier. But the Defence Ministry has rendered its services in the second wave too. DRDO has set up Covid hospitals and oxygen generation plants in Delhi, Lucknow, Varanasi, and many other parts of the country.

10,000 sachets of anti-COVID drug 2-DG to be available in market from today: Rajnath Singh

10,000 sachets of anti-COVID drug 2-DG to be available in market from today, says Rajnath Singh

10,000 sachets of anti-COVID drug 2-DG to be available in market from today: Rajnath Singh

10,000 sachets of anti-COVID drug 2-DG to be available in market from today: Rajnath Singh The anti-COVID drug has been developed by the Defence Research and Development Organisation (DRDO). Launching the ‘Services e-Health Assistance and Tele-consultation (SeHAT)’ OPD Portal via video conferencing, Singh lauded the armed forces, stating that it is a key step taken at a very critical time for the health of service personnel as it will reduce the load of the hospitals. Chief of Defence Staff Gen Bipin Rawat, Army Chief Gen M M Naravane, and Navy Chief Admiral Karambir Singh were among those who attended the event.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.